Olink Holding AB (publ) Net Profit Margin 2020-2023 | OLK

Olink Holding AB (publ) net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Olink Holding AB (publ) Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $0.17B $-0.03B -18.93%
2023-09-30 $0.16B $-0.02B -12.03%
2023-06-30 $0.15B $-0.02B -12.33%
2023-03-31 $0.15B $-0.02B -10.34%
2022-12-31 $0.14B $-0.01B -9.22%
2022-09-30 $0.13B $-0.03B -23.62%
2022-06-30 $0.12B $-0.03B -29.57%
2022-03-31 $0.11B $-0.04B -38.10%
2021-12-31 $0.10B $-0.04B -43.75%
2021-09-30 $0.08B $-0.02B -30.38%
2021-06-30 $0.07B $-0.02B -32.86%
2021-03-31 $0.06B $-0.02B -30.00%
2020-12-31 $0.05B $-0.02B -35.19%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.820B $0.170B
Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.723B 19.61
Inspire Medical Systems (INSP) United States $7.393B 0.00
IRhythm Technologies (IRTC) United States $3.477B 0.00
Axonics (AXNX) United States $3.412B 0.00
10x Genomics (TXG) United States $3.208B 0.00
Enovis (ENOV) United States $3.038B 23.08
Azenta (AZTA) United States $2.905B 236.82
Hims & Hers Health (HIMS) United States $2.680B 0.00
Privia Health (PRVA) United States $2.139B 94.89
Schrodinger (SDGR) United States $1.827B 0.00
Omnicell (OMCL) United States $1.248B 30.53
Phreesia (PHR) United States $1.185B 0.00
Definitive Healthcare (DH) United States $0.821B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.680B 0.00
Fulgent Genetics (FLGT) United States $0.619B 0.00
Talkspace (TALK) United States $0.536B 0.00
Health Catalyst (HCAT) United States $0.373B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.329B 0.00
Clover Health Investments (CLOV) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
P3 Health Partners (PIII) United States $0.183B 0.00
Butterfly Network (BFLY) United States $0.164B 0.00
American Well (AMWL) United States $0.154B 0.00
Outset Medical (OM) United States $0.147B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
Augmedix (AUGX) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.04
111 (YI) China $0.088B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.048B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00